BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 23244111)

  • 1. Synaptic vesicle protein 2 (SV2) isoforms.
    Bandala C; Miliar-García A; Mejía-Barradas CM; Anaya-Ruiz M; Luna-Arias JP; Bazán-Méndez CI; Gómez-López M; Juárez-Méndez S; Lara-Padilla E
    Asian Pac J Cancer Prev; 2012; 13(10):5063-7. PubMed ID: 23244111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum neurotoxin type A inhibits synaptic vesicle 2 expression in breast cancer cell lines.
    Bandala C; Cortés-Algara AL; Mejía-Barradas CM; Ilizaliturri-Flores I; Dominguez-Rubio R; Bazán-Méndez CI; Floriano-Sánchez E; Luna-Arias JP; Anaya-Ruiz M; Lara-Padilla E
    Int J Clin Exp Pathol; 2015; 8(7):8411-8. PubMed ID: 26339411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SV2C is a synaptic vesicle protein with an unusually restricted localization: anatomy of a synaptic vesicle protein family.
    Janz R; Südhof TC
    Neuroscience; 1999; 94(4):1279-90. PubMed ID: 10625067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SV2 is the protein receptor for botulinum neurotoxin A.
    Dong M; Yeh F; Tepp WH; Dean C; Johnson EA; Janz R; Chapman ER
    Science; 2006 Apr; 312(5773):592-6. PubMed ID: 16543415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of two human neuroblastoma cell lines alters SV2 expression patterns.
    Lekholm E; Ceder MM; Forsberg EC; Schiöth HB; Fredriksson R
    Cell Mol Biol Lett; 2021 Feb; 26(1):5. PubMed ID: 33588752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of synaptic vesicle protein 2 (SV2) isoforms.
    Bajjalieh SM; Frantz GD; Weimann JM; McConnell SK; Scheller RH
    J Neurosci; 1994 Sep; 14(9):5223-35. PubMed ID: 8083732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression pattern of synaptic vesicle protein 2 (SV2) isoforms in patients with temporal lobe epilepsy and hippocampal sclerosis.
    Crèvecoeur J; Kaminski RM; Rogister B; Foerch P; Vandenplas C; Neveux M; Mazzuferi M; Kroonen J; Poulet C; Martin D; Sadzot B; Rikir E; Klitgaard H; Moonen G; Deprez M
    Neuropathol Appl Neurobiol; 2014 Feb; 40(2):191-204. PubMed ID: 23617838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SV2A and SV2C are not vesicular Ca2+ transporters but control glucose-evoked granule recruitment.
    Iezzi M; Theander S; Janz R; Loze C; Wollheim CB
    J Cell Sci; 2005 Dec; 118(Pt 23):5647-60. PubMed ID: 16306227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons.
    Dong M; Liu H; Tepp WH; Johnson EA; Janz R; Chapman ER
    Mol Biol Cell; 2008 Dec; 19(12):5226-37. PubMed ID: 18815274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SV2A and SV2C contain a unique synaptotagmin-binding site.
    Schivell AE; Mochida S; Kensel-Hammes P; Custer KL; Bajjalieh SM
    Mol Cell Neurosci; 2005 May; 29(1):56-64. PubMed ID: 15866046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of SV2C mRNA and protein expression in the mouse brain with a particular emphasis on the basal ganglia system.
    Dardou D; Dassesse D; Cuvelier L; Deprez T; De Ryck M; Schiffmann SN
    Brain Res; 2011 Jan; 1367():130-45. PubMed ID: 20869353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptic vesicle protein 2b is expressed temporospatially in (pre)odontoblasts in developing molars.
    Yang SY; Jeon SK; Kang JH; Yoo HI; Kim YS; Moon JS; Kim MS; Koh JT; Oh WM; Kim SH
    Eur J Oral Sci; 2012 Dec; 120(6):505-12. PubMed ID: 23167466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural Transdifferentiation: MAPTau Gene Expression in Breast Cancer Cells.
    Lara-Padilla E; Miliar-Garcia A; Gomez-Lopez M; Romero-Morelos P; Bazan-Mendez C; Alfaro-Rodriguez A; Anaya-Ruiz M; Callender K; Carlos A; Bandala C
    Asian Pac J Cancer Prev; 2016; 17(4):1967-71. PubMed ID: 27221882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profile of synaptic vesicle glycoprotein 2A, B, and C paralogues in temporal neocortex tissue from patients with temporal lobe epilepsy (TLE).
    Pazarlar BA; Aripaka SS; Petukhov V; Pinborg L; Khodosevich K; Mikkelsen JD
    Mol Brain; 2022 May; 15(1):45. PubMed ID: 35578248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential distribution and developmental expression of synaptic vesicle protein 2 isoforms in the mouse retina.
    Wang MM; Janz R; Belizaire R; Frishman LJ; Sherry DM
    J Comp Neurol; 2003 May; 460(1):106-22. PubMed ID: 12687700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of SV2 isoforms during rodent brain development.
    Crèvecœur J; Foerch P; Doupagne M; Thielen C; Vandenplas C; Moonen G; Deprez M; Rogister B
    BMC Neurosci; 2013 Aug; 14():87. PubMed ID: 23937191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Evaluation of Silibinin Effects on Cell Cycling and Apoptosis in Human Breast Cancer MCF-7 and T47D Cell Lines.
    Jahanafrooz Z; Motameh N; Bakhshandeh B
    Asian Pac J Cancer Prev; 2016; 17(5):2661-5. PubMed ID: 27268647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain contains two forms of synaptic vesicle protein 2.
    Bajjalieh SM; Peterson K; Linial M; Scheller RH
    Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2150-4. PubMed ID: 7681585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the In Vivo Specificity of [
    Serrano ME; Becker G; Bahri MA; Seret A; Mestdagh N; Mercier J; Mievis F; Giacomelli F; Lemaire C; Salmon E; Luxen A; Plenevaux A
    Molecules; 2019 May; 24(9):. PubMed ID: 31052478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of low molecular weight protein tyrosine phosphatase isoforms in human breast cancer epithelial cell lines.
    Alho I; Costa L; Bicho M; Coelho C
    Anticancer Res; 2013 May; 33(5):1983-7. PubMed ID: 23645747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.